<mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd"><mods:titleInfo><mods:title>Improving Health Maintenance Measures: Effect of Pre-Visit Planning on Shingrix Vaccination Rates</mods:title></mods:titleInfo><mods:typeOfResource authority="primo">images</mods:typeOfResource><mods:abstract>Background: It is the responsibility of the provider to ensure that patients are aware and up to date with their health maintenance measures. These measures include vaccinations and cancer screenings which must be completed along certain timelines. With COVID-19 limiting annual visits, many doctors have low percentages for the number of patients that are up to date with these measures.
Objectives: To improve these percentages, a method of pre-visit planning was implemented over the course of two weeks to assess its effectiveness.
Methods: The study conducted was a quantitative study with an intervention method that consisted of chart auditing. A convenience sample of 442 charts of patients scheduled for visits between February 7th and 18th at Brown Internal Medicine were audited for any pending health maintenance activities. Charts with activities due had a pre visit note placed in the notes section for the upcoming visit. The charts were reviewed after the visit to determine if the activity occurred. This data was then compared to a convenience sample of 98 charts from January 31st and February 1st that did not have pre visit planning.
Results: Of the 442 patients seen, 206 needed the shingrix vaccine and 15 received it. Of the 98 control patients, 54 of them needed the vaccine and 4 of them received it. Vaccination rates went from 7.4% without planning to 7.28% with planning. The difference between the two groups was a decrease of 0.12% with pre-visit planning in place.
Conclusion: Based on the results it is reasonable to conclude that pre-visit planning did not provide a serious benefit to improving vaccination rates. Therefore it would not be prudent to implement pre-visit planning at clinic sites. However, there are possible reasons for this outcome that could have influenced the data.</mods:abstract><mods:name><mods:namePart>Glattstein, Aliya</mods:namePart><mods:role><mods:roleTerm authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/aut">Author</mods:roleTerm></mods:role></mods:name><mods:name><mods:namePart>Nassar, Carolyn Joy</mods:namePart><mods:role><mods:roleTerm authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/aut">Author</mods:roleTerm></mods:role></mods:name><mods:name><mods:namePart>Gutman, Deborah</mods:namePart><mods:role><mods:roleTerm authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/aut">Author</mods:roleTerm></mods:role></mods:name><mods:originInfo><mods:dateCreated>2022</mods:dateCreated></mods:originInfo><mods:subject authority="local"><mods:topic>Vaccination</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Pre-visit Planning</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>shingrix</mods:topic></mods:subject><mods:genre>posters</mods:genre><mods:accessCondition type="use and reproduction">All rights reserved</mods:accessCondition><mods:accessCondition type="rights statement" xlink:href="http://rightsstatements.org/vocab/InC/1.0/">In Copyright</mods:accessCondition><mods:accessCondition type="restriction on access">All Rights Reserved</mods:accessCondition><mods:identifier type="doi">10.26300/84z1-f631</mods:identifier></mods:mods>